FunPep Company Limited (TYO:4881)
Japan · Delayed Price · Currency is JPY 94.00
+1.00 (1.08%)
Feb 17, 2026, 9:14 AM JST
FunPep Company Company Description
FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.
The company is developing SR-0379, a functional peptide for skin ulcer; FPP003, an antibody-inducing peptide that is in Phase II clinical study for the treatment of psoriasis in Australia, as well as phase II clinical trial for ankylosing spondylitis in Japan; and FPP004X, an antibody-inducing peptide for pollinosis.
It is also developing FPP006, a corona peptide vaccine; and FPP005, a antibody including peptide for psoriasis.
FunPep Company Limited was incorporated in 2013 and is based in Ibaraki, Japan.
FunPep Company Limited
| Country | Japan |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Toshimi Miyoshi |
Contact Details
Address: 7-15 Asagi 7-chome Ibaraki , 151-0051 Japan | |
| Phone | 81 3 5315 4200 |
| Website | funpep.co.jp |
Stock Details
| Ticker Symbol | 4881 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3802640007 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Toshimi Miyoshi | Chief Executive Officer |
| Taketoshi Hayashi | Chief Financial Officer |